OncoSec Medical Incorporated (ONCS) Fundamentals

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.
SHARE INFORMATION
Market Cap$ 29,119,269
Shares Outstanding39,350,363
Float18,985,633
Percent Float48.25%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.40
Latest Fiscal Date2021-07-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions67
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months306,134
Institutional Holdings Percent19.3%
Institutional Sold Previous 3 Months514,080
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent6.8
Insider Sold Previous 3 Months-
Insider Shares Owned2,666,943
TRADING INFO
52 Week High$ 4.25
52 Week Low$ 0.67
52 Week High Change$ -81.41
21 Day Moving Average$ 0.791
21 Day Extended Moving Average$ 0.807326
50 Day Moving Average$ 0.9678
50 Day Extended Moving Average$ 0.902743
200 Day Moving Average$ 1.3778
200 Day Extended Moving Average$ 1.5375
10 Day Average Volume68,719
20 Day Average Volume76,679
30 Day Average Volume73,936
50 Day Average Volume96,281
Alpha-0.032051
Beta2.0331
Standard Deviation0.265558
R20.131344
7 Day Price Change$ 0.04
7 Day Percent Change5.71%
21 Day Price Change$ -0.0402
21 Day Percent Change-5.15%
30 Day Price Change$ -0.2452
30 Day Percent Change-24.89%
Month to Date Price Change$ -0.1097
Month to Date Percent Change-12.91%
Quarter to Date Price Change$ -0.41
Quarter to Date Percent Change-35.65%
180 Day Price Change$ -0.86
180 Day Percent Change-53.75%
200 Day Price Change$ -0.91
200 Day Percent Change-55.15%
Year to Date Price Change$ -0.2196
Year to Date Percent Change-22.88%

OncoSec Medical Incorporated (ONCS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.50
Total Debt To Equity0.30
Int Coverage-2,352.30
Current Ratio5.00
Leverage Ratio1.90
Quick Ratio4.50
Long Term Debt To Capital0.19
VALUATION MEASURES
PE Ratio-0.70
Enterprise Value$ 10,082,087
Price to Sales0.00
Price to Free Cash-1.00
PE High Last 5 Years-1.10
Price To Book1.50
Price To Cash Flow0.00
PE Low Last 5 Years-0.80
Price to Tangible Book1.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-82.03
Return on Equity-127.28
Return on Capital-100.04

OncoSec Medical Incorporated (ONCS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMayer Hoffman McCann P.C.
CEOKevin R. Smith
Emplyoees58
Last AuditUE
CIK0001444307
IndustryBiotechnology
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address3565 General Atomics Court
Suite 100
San Diego, CA 92121
Websitehttps://www.oncosec.com
Facsimile+1 858 430-3832
Telephone+1 855 662-6732
Emailinvestors@oncosec.com


Your Recent History
NASDAQ
ONCS
OncoSec Me..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.